Alba Llop-Guevara

10PUBLICATIONS
201CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

|Mar 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer.

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino

|Jan 09, 2025
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial.

Guillermo Villacampa, Alba Llop-Guevara, Natalie Filmann

|Mar 21, 2024
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.

Alejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara

|Sep 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Alistair Ring, Lucy S Kilburn, Alex Pearson

|Jul 28, 2023
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.

Claire Jh Kramer, Alba Llop-Guevara, Elisa Yaniz-Galende

Pageof 2

Frequent Collaborators

10 joint publications

Violeta Serra

4 joint publications

Andrea Herencia-Ropero

4 joint publications

Judith Balmaña

3 joint publications

Benedetta Pellegrino